Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | N-formyl peptide receptor 2 |
---|
Ligand | BDBM37605 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Dose Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Dose Response Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands |
---|
Ki | >40300±n/a nM |
---|
Comments | Extracted from aid = 520 and tid = 2 |
---|
Citation | PubChem, PC Dose Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Dose Response Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands PubChem Bioassay(2007)[AID] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
N-formyl peptide receptor 2 |
---|
Name: | N-formyl peptide receptor 2 |
Synonyms: | ALXR, FPRL1, FPR2 | FMLP-related receptor I FMLP-R-I | FPR2 | FPR2_HUMAN | FPRH1 | FPRL1 | Formyl Peptide Receptor-Like 1 | HM63 | LXA4 receptor | LXA4R | Lipoxin A4 receptor | Lipoxin A4 receptor (LXA4) | RFP | hFPRL |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 38968.35 |
Organism: | Homo sapiens (Human) |
Description: | P25090 |
Residue: | 351 |
Sequence: | METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVT
TICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIA
LDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNF
ASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPL
RVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPM
LYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
|
|
|
BDBM37605 |
---|
n/a |
---|
Name | BDBM37605 |
Synonyms: | 2-Cyano-N-(2-ethyl-phenyl)-2-pyridin-3-ylmethyl-acetamide | 2-cyano-N-(2-ethylphenyl)-3-(3-pyridinyl)propanamide | 2-cyano-N-(2-ethylphenyl)-3-(3-pyridyl)propionamide | 2-cyano-N-(2-ethylphenyl)-3-pyridin-3-yl-propanamide | 2-cyano-N-(2-ethylphenyl)-3-pyridin-3-ylpropanamide | MLS000035720 | SMR000002073 | cid_646700 |
Type | Small organic molecule |
Emp. Form. | C17H17N3O |
Mol. Mass. | 279.3364 |
SMILES | CCc1ccccc1NC(=O)C(Cc1cccnc1)C#N |
Structure |
|